View in EDS

T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.

Saved in:
Bibliographic Details
Title: T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.
Authors: Gainor JF; Massachusetts General Hospital, Boston, Massachusetts., Patel MR; Florida Cancer Specialists, Sarasota, Florida.; Sarah Cannon Research Institute, Nashville, Tennessee., Weber JS; Perlmutter Cancer Center at NYU Langone Health, New York, New York., Gutierrez M; Hackensack University Medical Center, Hackensack, New Jersey., Bauman JE; George Washington University Cancer Center, Washington, District of Columbia., Clarke JM; Duke University Medical Center, Durham, North Carolina., Julian R; University of Arizona Cancer Center, Tucson, Arizona., Scott AJ; University of Arizona Cancer Center, Tucson, Arizona., Geiger JL; The Cleveland Clinic Foundation, Cleveland, Ohio., Kirtane K; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Robert-Tissot C; Moderna, Inc., Cambridge, Massachusetts., Coder B; Moderna, Inc., Cambridge, Massachusetts., Tasneem M; Moderna, Inc., Cambridge, Massachusetts., Sun J; Moderna, Inc., Cambridge, Massachusetts., Zheng W; Moderna, Inc., Cambridge, Massachusetts., Gerbereux L; Moderna, Inc., Cambridge, Massachusetts., Laino A; Moderna, Inc., Cambridge, Massachusetts., Porichis F; Moderna, Inc., Cambridge, Massachusetts., Pollard JR; Moderna, Inc., Cambridge, Massachusetts., Hou P; Moderna, Inc., Cambridge, Massachusetts., Sehgal V; Moderna, Inc., Cambridge, Massachusetts., Chen X; Moderna, Inc., Cambridge, Massachusetts., Morrissey M; Moderna, Inc., Cambridge, Massachusetts., Daghestani HN; Moderna, Inc., Cambridge, Massachusetts., Feldman I; Moderna, Inc., Cambridge, Massachusetts., Srinivasan L; Moderna, Inc., Cambridge, Massachusetts., Frederick JP; Moderna, Inc., Cambridge, Massachusetts., Brown M; Moderna, Inc., Cambridge, Massachusetts., Aanur P; Moderna, Inc., Cambridge, Massachusetts., Meehan R; Moderna, Inc., Cambridge, Massachusetts., Burris HA 3rd; Sarah Cannon Research Institute, Nashville, Tennessee.
Source: Cancer discovery [Cancer Discov] 2024 Nov 01; Vol. 14 (11), pp. 2209-2223.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39115419
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gainor+JF%22">Gainor JF</searchLink>; Massachusetts General Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Patel+MR%22">Patel MR</searchLink>; Florida Cancer Specialists, Sarasota, Florida.; Sarah Cannon Research Institute, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Weber+JS%22">Weber JS</searchLink>; Perlmutter Cancer Center at NYU Langone Health, New York, New York.<br /><searchLink fieldCode="AU" term="%22Gutierrez+M%22">Gutierrez M</searchLink>; Hackensack University Medical Center, Hackensack, New Jersey.<br /><searchLink fieldCode="AU" term="%22Bauman+JE%22">Bauman JE</searchLink>; George Washington University Cancer Center, Washington, District of Columbia.<br /><searchLink fieldCode="AU" term="%22Clarke+JM%22">Clarke JM</searchLink>; Duke University Medical Center, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Julian+R%22">Julian R</searchLink>; University of Arizona Cancer Center, Tucson, Arizona.<br /><searchLink fieldCode="AU" term="%22Scott+AJ%22">Scott AJ</searchLink>; University of Arizona Cancer Center, Tucson, Arizona.<br /><searchLink fieldCode="AU" term="%22Geiger+JL%22">Geiger JL</searchLink>; The Cleveland Clinic Foundation, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Kirtane+K%22">Kirtane K</searchLink>; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Robert-Tissot+C%22">Robert-Tissot C</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Coder+B%22">Coder B</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Tasneem+M%22">Tasneem M</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Sun+J%22">Sun J</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Zheng+W%22">Zheng W</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Gerbereux+L%22">Gerbereux L</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Laino+A%22">Laino A</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Porichis+F%22">Porichis F</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Pollard+JR%22">Pollard JR</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Hou+P%22">Hou P</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Sehgal+V%22">Sehgal V</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Morrissey+M%22">Morrissey M</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Daghestani+HN%22">Daghestani HN</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Feldman+I%22">Feldman I</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Srinivasan+L%22">Srinivasan L</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Frederick+JP%22">Frederick JP</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Brown+M%22">Brown M</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Aanur+P%22">Aanur P</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Meehan+R%22">Meehan R</searchLink>; Moderna, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Burris+HA+3rd%22">Burris HA 3rd</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101561693%22">Cancer discovery</searchLink> [Cancer Discov] 2024 Nov 01; Vol. 14 (11), pp. 2209-2223.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101561693 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-8290 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221598274%22">21598274 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Discov <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39115419
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2159-8290.CD-24-0158
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2209
    Titles:
      – TitleFull: T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gainor JF
      – PersonEntity:
          Name:
            NameFull: Patel MR
      – PersonEntity:
          Name:
            NameFull: Weber JS
      – PersonEntity:
          Name:
            NameFull: Gutierrez M
      – PersonEntity:
          Name:
            NameFull: Bauman JE
      – PersonEntity:
          Name:
            NameFull: Clarke JM
      – PersonEntity:
          Name:
            NameFull: Julian R
      – PersonEntity:
          Name:
            NameFull: Scott AJ
      – PersonEntity:
          Name:
            NameFull: Geiger JL
      – PersonEntity:
          Name:
            NameFull: Kirtane K
      – PersonEntity:
          Name:
            NameFull: Robert-Tissot C
      – PersonEntity:
          Name:
            NameFull: Coder B
      – PersonEntity:
          Name:
            NameFull: Tasneem M
      – PersonEntity:
          Name:
            NameFull: Sun J
      – PersonEntity:
          Name:
            NameFull: Zheng W
      – PersonEntity:
          Name:
            NameFull: Gerbereux L
      – PersonEntity:
          Name:
            NameFull: Laino A
      – PersonEntity:
          Name:
            NameFull: Porichis F
      – PersonEntity:
          Name:
            NameFull: Pollard JR
      – PersonEntity:
          Name:
            NameFull: Hou P
      – PersonEntity:
          Name:
            NameFull: Sehgal V
      – PersonEntity:
          Name:
            NameFull: Chen X
      – PersonEntity:
          Name:
            NameFull: Morrissey M
      – PersonEntity:
          Name:
            NameFull: Daghestani HN
      – PersonEntity:
          Name:
            NameFull: Feldman I
      – PersonEntity:
          Name:
            NameFull: Srinivasan L
      – PersonEntity:
          Name:
            NameFull: Frederick JP
      – PersonEntity:
          Name:
            NameFull: Brown M
      – PersonEntity:
          Name:
            NameFull: Aanur P
      – PersonEntity:
          Name:
            NameFull: Meehan R
      – PersonEntity:
          Name:
            NameFull: Burris HA 3rd
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2024 Nov 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2159-8290
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Cancer discovery
              Type: main
ResultId 1